NATCO PHARMA Good time to enter and Hold onWeekly resistance in place, Expect the safe path to give support intact.
Accumulate in phases. Good to touch all time HIGH (ATH) soon, if Strong support line hold.
NATCO Pharma Limited
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
85.90 INR
18.85 B INR
44.15 B INR
86.87 M
About NATCO Pharma Limited
Sector
Industry
CEO
Rajeev Nannapaneni
Website
Headquarters
Hyderabad
Founded
1981
Identifiers
2
ISIN:INE987B01026
NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.
Related stocks
NATCOPHARM CMP 935.(Low Risk High Reward Setup).From last two years stock was in a correction phase.Was respecting a down trendline. Now indicating a trendline breakout. Bollinger band also squeez and RSI indicating strenth in price.Suddenly volume increased show some exra activty in this counter. So add this to your watchlist and see how it perf
NATCO Pharma | Volume Profile ContextKey observations:
Marked High Volume Nodes (HVN) indicate strong participation zones
POC area reflects the highest traded price (fair value)
Price may rotate between volume clusters based on acceptance or rejection
These levels act as reference zones, not trade calls
This idea helps understand
NATCOPHARM | Buy @LTP | SL below 800 | 1st Target 1045Disclaimer (Please Read Carefully):
This is not investment advice. The stocks shared here are purely for educational and informational purposes. Please do your own research or consult with a financial advisor before making any investment decisions.
*************************************************
Natco Pharma Ltd for 14th Oct #NATCOPHARM Natco Pharma Ltd for 14th Oct #NATCOPHARM
Resistance 850 Watching above 851 for upside momentum.
Support area 840 Below 840 gnoring upside momentum for intraday
Watching below 838 for downside movement...
Above 850 ignoring downside move for intraday
Charts for Educational purposes only.
Please
Life Insurance Corporation of India Ltd for 10th Oct #LICI Life Insurance Corporation of India Ltd for 10th Oct #LICI
Resistance 850 Watching above 851 for upside momentum.
Support area 840 Below 840 gnoring upside momentum for intraday
Watching below 838 for downside movement...
Above 850 ignoring downside move for intraday
Charts for Educational purpo
NATCOPharma - HIGH RISKPlease follow the levels on the chart.
Please calculate the risk involved in initiating the position.
Please stick to the SL and Targets.
NATCO PHARMA LTD FOR YOU!Everything is pretty much explained in the picture itself.
I am Abhishek Srivastava | SEBI-Certified Research and Equity Derivative Analyst from Delhi with 4+ years of experience.
I focus on simplifying equity markets through technical analysis. On Trading View, I share easy-to-understand insights
NATCO , reversal breakNATCO Pharma, after a downtrend, moving in a higher high pattern. Hope fully a break out from this trend line. Lets see how it may behave from here. next levels have been provided.
NATCOPHARM Swing TradeNATCOPHARM Swing Trade
Buy Price - 1318
T1 - 1730 (Time Frame - 4 to 6 Months)
T2 - 2600 (Time Frame - 6 to 12 months)
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SMALLCAP
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF Units Exchange Traded FundWeight
0.71%
Market value
568.65 K
USD
TLTE
FlexShares Morningstar Emerging Markets Factor Tilt Index FundWeight
0.14%
Market value
390.71 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of NATCOPHARM is 906.10 INR — it has decreased by −1.40% in the past 24 hours. Watch NATCO Pharma Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange NATCO Pharma Limited stocks are traded under the ticker NATCOPHARM.
NATCOPHARM stock has fallen by −4.33% compared to the previous week, the month change is a 13.95% rise, over the last year NATCO Pharma Limited has showed a −38.21% decrease.
We've gathered analysts' opinions on NATCO Pharma Limited future price: according to them, NATCOPHARM price has a max estimate of 1,160.00 INR and a min estimate of 712.00 INR. Watch NATCOPHARM chart and read a more detailed NATCO Pharma Limited stock forecast: see what analysts think of NATCO Pharma Limited and suggest that you do with its stocks.
NATCOPHARM reached its all-time high on Sep 12, 2024 with the price of 1,638.35 INR, and its all-time low was 7.60 INR and was reached on Oct 27, 2008. View more price dynamics on NATCOPHARM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NATCOPHARM stock is 2.54% volatile and has beta coefficient of 1.39. Track NATCO Pharma Limited stock price on the chart and check out the list of the most volatile stocks — is NATCO Pharma Limited there?
Today NATCO Pharma Limited has the market capitalization of 164.59 B, it has decreased by −8.57% over the last week.
Yes, you can track NATCO Pharma Limited financials in yearly and quarterly reports right on TradingView.
NATCO Pharma Limited is going to release the next earnings report on Feb 18, 2026. Keep track of upcoming events with our Earnings Calendar.
NATCOPHARM earnings for the last quarter are 29.00 INR per share, whereas the estimation was 24.55 INR resulting in a 18.10% surprise. The estimated earnings for the next quarter are 1.20 INR per share. See more details about NATCO Pharma Limited earnings.
NATCO Pharma Limited revenue for the last quarter amounts to 13.63 B INR, despite the estimated figure of 11.91 B INR. In the next quarter, revenue is expected to reach 5.41 B INR.
NATCOPHARM net income for the last quarter is 5.18 B INR, while the quarter before that showed 4.81 B INR of net income which accounts for 7.84% change. Track more NATCO Pharma Limited financial stats to get the full picture.
NATCO Pharma Limited dividend yield was 0.75% in 2024, and payout ratio reached 5.70%. The year before the numbers were 1.00% and 12.28% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 13, 2025, the company has 4.96 K employees. See our rating of the largest employees — is NATCO Pharma Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NATCO Pharma Limited EBITDA is 17.37 B INR, and current EBITDA margin is 50.90%. See more stats in NATCO Pharma Limited financial statements.
Like other stocks, NATCOPHARM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NATCO Pharma Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NATCO Pharma Limited technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NATCO Pharma Limited stock shows the neutral signal. See more of NATCO Pharma Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.